PMC:7796344 / 12554-13207 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"71","span":{"begin":207,"end":217},"obj":"Disease"},{"id":"72","span":{"begin":248,"end":259},"obj":"Disease"},{"id":"73","span":{"begin":296,"end":309},"obj":"Disease"},{"id":"75","span":{"begin":365,"end":378},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D008581"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D006509"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D011051"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D011051"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"3.4. Immunization History\nDespite the Umrah visa requirements, some pilgrims (n = 223; 22%) had not received any vaccination prior to travel; however, others had received influenza vaccine (n = 514; 50.8%), meningitis vaccination (n = 418; 41.3%), Hepatitis B vaccine (HBV) (n = 310; 30.6%), and poliomyelitis vaccination (n = 285; 28.1%) (Table 3).\nIn the case of poliomyelitis vaccination for pilgrims attending from countries listed at the time of the 2019 Umrah as polio active, some of the pilgrims had not taken a polio vaccine before travelling from at risk countries including Pakistan (n = 34/92; 31.2%) and Afghanistan (n = 16/80; 12.8%) [21]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":207,"end":217},"obj":"Phenotype"},{"id":"T13","span":{"begin":248,"end":257},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0001287"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"3.4. Immunization History\nDespite the Umrah visa requirements, some pilgrims (n = 223; 22%) had not received any vaccination prior to travel; however, others had received influenza vaccine (n = 514; 50.8%), meningitis vaccination (n = 418; 41.3%), Hepatitis B vaccine (HBV) (n = 310; 30.6%), and poliomyelitis vaccination (n = 285; 28.1%) (Table 3).\nIn the case of poliomyelitis vaccination for pilgrims attending from countries listed at the time of the 2019 Umrah as polio active, some of the pilgrims had not taken a polio vaccine before travelling from at risk countries including Pakistan (n = 34/92; 31.2%) and Afghanistan (n = 16/80; 12.8%) [21]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T92","span":{"begin":0,"end":4},"obj":"Sentence"},{"id":"T93","span":{"begin":5,"end":25},"obj":"Sentence"},{"id":"T94","span":{"begin":26,"end":349},"obj":"Sentence"},{"id":"T95","span":{"begin":350,"end":653},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3.4. Immunization History\nDespite the Umrah visa requirements, some pilgrims (n = 223; 22%) had not received any vaccination prior to travel; however, others had received influenza vaccine (n = 514; 50.8%), meningitis vaccination (n = 418; 41.3%), Hepatitis B vaccine (HBV) (n = 310; 30.6%), and poliomyelitis vaccination (n = 285; 28.1%) (Table 3).\nIn the case of poliomyelitis vaccination for pilgrims attending from countries listed at the time of the 2019 Umrah as polio active, some of the pilgrims had not taken a polio vaccine before travelling from at risk countries including Pakistan (n = 34/92; 31.2%) and Afghanistan (n = 16/80; 12.8%) [21]."}